Trial · NCT02143414
Adverse events1,788
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,788
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Induction: Cohort I (Ph-) | 17 | 29 | |
| other | Anemia | Blood and lymphatic system disorders | Induction: Cohort II (Ph+/Ph-like) | 13 | 24 | |
| other | Anemia | Blood and lymphatic system disorders | Post-remission: Cohort I (Ph-) | 9 | 19 | |
| other | Anemia | Blood and lymphatic system disorders | Post-remission: Cohort II (Ph+/Ph-like) | 12 | 18 | |
| other | Anemia | Blood and lymphatic system disorders | Maintenance: Cohort I (Ph-) | 9 | 13 | |
| other | Anemia | Blood and lymphatic system disorders | Maintenance: Cohort II (Ph+/Ph-like) | 9 | 16 | |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Induction: Cohort I (Ph-) | 1 | 29 | |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Induction: Cohort II (Ph+/Ph-like) | 1 | 24 | |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Post-remission: Cohort I (Ph-) | 0 | 19 | |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Post-remission: Cohort II (Ph+/Ph-like) | 0 | 18 | |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Maintenance: Cohort I (Ph-) | 0 | 13 | |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Maintenance: Cohort II (Ph+/Ph-like) | 2 | 16 | |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Induction: Cohort I (Ph-) | 2 | 29 | |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Induction: Cohort II (Ph+/Ph-like) | 1 | 24 | |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Post-remission: Cohort I (Ph-) | 1 | 19 | |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Post-remission: Cohort II (Ph+/Ph-like) | 0 | 18 | |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Maintenance: Cohort I (Ph-) | 0 | 13 | |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Maintenance: Cohort II (Ph+/Ph-like) | 0 | 16 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Induction: Cohort I (Ph-) | 6 | 29 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Induction: Cohort II (Ph+/Ph-like) | 1 | 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02143414/events